🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

RecruitingNAAges 20 Years - 90 YearsAllNational Taipei University of Nursing and Health …
NCT07196488 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: For Patients: 1. Diagnosed with prostate cancer by a board-certified urologist. 2. Has either decided on a treatment plan or completed treatment within the past two years. 3. Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. For Spouses: 1. Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older. 2. Must have a Barthel Index score of 91 or above, indicating good functional independence. Exclusion Criteria: Either the patient or the spouse will be excluded if: 1. Diagnosed with another type of cancer. 2. Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
💊

What it tests

  • Dyadic Co-learning Intervention
📍

Where

2 sites
Keelung Chang Gung Memorial Hospital
Keelung, Taiwan
LinKou Chang Gung Memorial Hospital
Taoyuan, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy